Molecular Coronavirus SARS-CoV-2
Designed to support laboratories in detecting and identifying SARS-CoV-2, this program remains essential for assessing assays against current and evolving strains. It provides simulated respiratory samples to best replicate clinical samples to assess the entire testing process and ensure accurate and reliable patient results. Developed in collaboration with WHO reference laboratories, the program has proven instrumental in identifying key mutations, such as Omicron, and is positioned to meet ongoing and future laboratory needs as the virus evolves, enabling the review and critical analysis of assay target genes.